SITE MAP 
  HOME  
PHARMA
BIO TECHNOLOGY
MEDICAL TECHNOLOGY
  JOBS  
  FREE SUBSCRIPTION  
  Saturday, July 26, 2008 SEARCH     
 
 
BIO AUSTRALIA
BIO CHINA
BIO INDIA
BIO INDONESIA
BIO JAPAN
BIO KOREA
BIO MALAYSIA
BIO NEW ZEALAND
BIO PHILIPPINES
BIO SINGAPORE
BIO TAIWAN
BIO THAILAND
 
 
Get the latest news on life sciences in your mail box
Name
E-Mail Id
 
 
Advertisement











 
Bio Technology  News  Story
Panacea Biotec to supply vaccines in Philippines

Bangalore, Oct 5, 2007: India-based Panacea Biotec has entered into a Memorandum of Agreement (MoA) with Family Vaccines of Philippines to provide access to value added combination vaccines under the umbrella of ‘Easy Vaccines’ manufactured by Panacea Biotec, to the people in Philippines through a chain of 50 immunization clinics, run by Family Vaccines.
 
Panacea Biotec has been playing an imperative role in immunization through its novel and innovative, world’s first fully liquid vaccine with brands such as, ‘Easy Four’ & ‘Easy Five’, for over three years. It has partnered with WHO and UNICEF with a mission of supporting the cause of maximizing coverage of vaccines under the Expanded Program on Immunization (EPI) for more than a decade.
 
Philippines has a birth cohort of around 2.5 million with an EPI immunization coverage of about 80 percent. At a GNI per capita at USD 1170 and a GDP per capita at USD 4614, Philippines has been accorded a developing country status. The global vaccine market is expected to top $10 billion in 2007 and $23.8 billion in 2012.
 
The MOA was signed between Mr Rajesh Jain, JMD, Panacea Biotec and Mr Jaime Enrique Gonzalez, Managing Director of Family Vaccines on the platform of Confederation of Indian Industries (CII ) in Mumbai, India on October 4, 2007.
 
Speaking on the occasion, Mr Rajesh Jain, JMD, Panacea Biotec says, “Panacea Biotec has built an innovative portfolio in combination vaccines under ‘Easy’ range of vaccines which has enabled it achieve a leadership position in just about two years of its launch in India. While fully liquid DTP combos would be the arena of focus to start the partnership with Family Vaccine, it would eventually work towards introduction of Polprotec (IPV) and its combination vaccines in due course. With a very strong, innovative product pipeline in immunization, Panacea Biotec is all set to venture into global markets.”
 
“The partnership with Panacea Biotec, a leading research based healthcare company of India, will enable us in formation of a forum to facilitate sharing of novel concepts in immunization and pediatric practice between the two countries. In addition to providing access to the value added ‘Easy’ range of combination vaccines through the chain of immunization clinics in Phillipines, this strategic partnership is also aimed at taking part in immunization program of vaccines in EPI through institutional supplies and the Medical practitioners involved in immunization. Family Vaccines & Specialty Clinics is the leading and the largest privately run chain of vaccine clinics in Philippines,” said Mr Jaime Enrique Gonzalez, Managing Director of Family Vaccines, Philippines.
 

© BioSpectrum Bureau
  Email this articleComment on this article   Print this article
 
Advertisement





 
   
 
Google
BioSpectrumAsia.com BioSpectrumIndia.com Web

About BioSpectrum | How to Advertise | Jobs at BioSpectrum | Contact Us | Privacy Statement



CyberMedia Network Websites


[Voice&Data]  [PCQuest]  [CIOL]  [Dataquest]  [Living Digital]  [IDC India]
[CIOL Shop]  [DQ Channels]  [The DQweek]  [CyberMedia Dice]  
[CyberMedia Events] [CyberMedia Digital]  [Cyber Astro]  [CyberMedia India]  [Global Services]  [BioSpectrum]

 
Copyrights are reserved for BioSpectrum ; Designed by : Altered Black